RespiriTB-1136242 Enzymatic Assay and Characterization of cyt bc1 & bd inhibitors report

Summary

The Enzymatic Assay and Characterization of cyt bc1 & bd inhibitors report will describe the assay, conditions and characterisation methodology of the enzymatic assay for testing cytochrome bc1 and cytochrome bd inhibitors.

More information & hyperlinks

Web resources:

https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e50fcea24a&appId=PPGMS

Associated projects

RespiriTB - Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors

Organisations

Not specified